The role of actigraphy in detecting and characterizing the early phases of Alzheimer's disease.
作者信息
Winer Joseph R
机构信息
Department of Neurology and Neurological Sciences, Stanford University, Stanford CA, USA.
出版信息
Sleep. 2024 May 10;47(5). doi: 10.1093/sleep/zsae076.
Abstract
摘要
相似文献
1
The role of actigraphy in detecting and characterizing the early phases of Alzheimer's disease.
Sleep. 2024 May 10;47(5). doi: 10.1093/sleep/zsae076.
2
Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adults.
Lancet Healthy Longev. 2020 Dec;1(3):e96-e105. doi: 10.1016/s2666-7568(20)30015-5. Epub 2020 Nov 12.
3
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.
J Prev Alzheimers Dis. 2021;8(3):371-386. doi: 10.14283/jpad.2021.23.
4
Sex differences in the relationships between 24-h rest-activity patterns and plasma markers of Alzheimer's disease pathology.
Alzheimers Res Ther. 2024 Dec 30;16(1):277. doi: 10.1186/s13195-024-01653-y.
5
Can the retina be used to diagnose and plot the progression of Alzheimer's disease?
Acta Ophthalmol. 2017 Dec;95(8):768-777. doi: 10.1111/aos.13472. Epub 2017 Jun 9.
6
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
7
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
8
(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2014 Jul 23;2014(7):CD010386. doi: 10.1002/14651858.CD010386.pub2.
9
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
10
Function of the hand as a predictor of early diagnosis and progression of Alzheimer's dementia: A systematic review.
Technol Health Care. 2024;32(S1):253-264. doi: 10.3233/THC-248022.
引用本文的文献
1
Associations between objective sleep metrics and brain structure in cognitively unimpaired adults: interactions with sex and Alzheimer's biomarkers.
Alzheimers Dement. 2025 Jun;21(6):e70353. doi: 10.1002/alz.70353.
2
Assessment of feasibility of actigraphy as a measure of clinical change in response to an experimental interventional treatment in adolescents and adults with autism spectrum disorder.
Front Psychiatry. 2025 May 23;16:1570611. doi: 10.3389/fpsyt.2025.1570611. eCollection 2025.
3
Transforming Sleep Monitoring: Review of Wearable and Remote Devices Advancing Home Polysomnography and Their Role in Predicting Neurological Disorders.
Biosensors (Basel). 2025 Feb 17;15(2):117. doi: 10.3390/bios15020117.
本文引用的文献
1
Evaluating a novel 24-hour rest/activity rhythm marker of preclinical β-amyloid deposition.
Sleep. 2024 May 10;47(5). doi: 10.1093/sleep/zsae037.
2
Day-to-day sleep variability with Alzheimer's biomarkers in at-risk elderly.
Alzheimers Dement (Amst). 2024 Feb 16;16(1):e12521. doi: 10.1002/dad2.12521. eCollection 2024 Jan-Mar.
3
State of the science and recommendations for using wearable technology in sleep and circadian research.
Sleep. 2024 Apr 12;47(4). doi: 10.1093/sleep/zsad325.
4
Study design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER).
Alzheimers Dement. 2024 Feb;20(2):769-782. doi: 10.1002/alz.13365. Epub 2023 Sep 30.
5
Night-to-night variability in sleep and amyloid beta burden in normal aging.
Alzheimers Dement (Amst). 2023 Sep 21;15(3):e12460. doi: 10.1002/dad2.12460. eCollection 2023 Jul-Sep.
6
Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates.
J Alzheimers Dis. 2023;94(2):601-610. doi: 10.3233/JAD-230094.
7
40 years of actigraphy in sleep medicine and current state of the art algorithms.
NPJ Digit Med. 2023 Mar 24;6(1):51. doi: 10.1038/s41746-023-00802-1.
8
Variability in objective sleep is associated with Alzheimer's pathology and cognition.
Brain Commun. 2023 Feb 16;5(2):fcad031. doi: 10.1093/braincomms/fcad031. eCollection 2023.
9
Exploring cognitive and biological correlates of sleep quality and their potential links with Alzheimer's disease (ALFASleep project): protocol for an observational study.
BMJ Open. 2022 Dec 30;12(12):e067159. doi: 10.1136/bmjopen-2022-067159.
10
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.
Nat Med. 2022 Nov;28(11):2381-2387. doi: 10.1038/s41591-022-02049-x. Epub 2022 Nov 10.
Zotero 插件